Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
68 /100
HIGH RISK
Score updated Oct 13, 2026

DARE — Daré Bioscience, Inc. Dilution Risk Tracker

Track DARE dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DARE — Get alerts when the score changes →

As of October 13, 2026, Daré Bioscience, Inc. (DARE) has a DilutionWatch DilutionScore of 68/100, rated HIGH dilution risk. Daré Bioscience, Inc. has a market capitalization of $11.47M, 15.29M shares outstanding, 26 institutional holders tracked. Stored dilution-related fields include 10.01M outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
46
💰 Cash Runway
85
📊 Float Risk
25
⚠️ Warrant Exposure
90
🔄 Convertible Debt
40

Dilution Forecast

⛈️
Warning
High probability of dilution event
model est. 43%
📜 Warrant Exercise model 60%
• Massive warrant overhang: 65% of shares outstanding
• Warrant risk score very high (90/100)
💰 Capital Raise model 35%
• Low cash runway: 4 months remaining
🔄 Reverse Split model est. 15%
• Only 4 months cash — financial pressure
🔔 Track DARE — Get forecast alerts →

Market Data

Market Cap$11.47M
Shares Outstanding15.29M
Float13.70M
Cash$12.62M
Debt$10.5K
Short InterestN/A

Source-Backed Evidence Depth

This public preview uses stored DilutionWatch fields and linked SEC/market records only. Missing values are not estimated.

FieldCurrent ValueBasis
DilutionScore68/100DilutionWatch score record
Shares Outstanding15.29MVerified float table or market cache
Public Float13.70MVerified float table or market cache
Market Cap$11.47MMarket data cache
Cash Runway4.5 monthsDilutionWatch score inputs
Shelf CapacityNone in current score inputsSEC-derived dilution fields
ATM CapacityNone in current score inputsSEC-derived dilution fields
Outstanding Warrants10.01MSEC-derived dilution fields

Recent source-backed SEC insight records available on this page: 7.

Recent SEC source mix: 4 1, 8-K 4, XBRL 2.

The page does not infer future share issuance, financing probability, cash needs, management intent, or price impact when source fields are absent.

Institutional Holdings

QoQ: ↑ 50.8% shares (2026Q1 vs prior)
26 institutional holders · 1.49M shares
#1 VANGUARD CAPITAL MANAGEMENT LLC 924.6K shares
#2 GEODE CAPITAL MANAGEMENT, LLC 177.8K shares
#3 US BANCORP \DE\ 91.4K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest922.0K
Days to Cover3.1
% of Float6.7%
FINRA data as of Sep 30, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-03-31
xbrl XBRL CONVERTIBLE 2019-04-01
8-K 8K EVENT 2026-04-20
8-K 8K EVENT 2026-04-13
8-K 8K EVENT 2026-03-17
Full SEC filing analysis available with free account →

Recent News

No recent news available for this ticker.

Factual DARE Dilution Snapshot

Daré Bioscience, Inc. (DARE) has a DilutionScore of 68/100, rated High dilution risk. Score date: October 13, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

DilutionScore History — Last 90 Days

DARE's DilutionScore is currently 68/100 (High risk), with 3 score changes tracked over 89 days. The score improved from 55/100 (High risk).

Period Score Risk Level Duration
Oct 01 – Oct 13, 202668/100HIGH13 days
Aug 27 – Sep 30, 202655/100HIGH35 days
Aug 22 – Aug 26, 202650/100MEDIUM5 days
Jul 16 – Aug 21, 202641/100MEDIUM36 days

Score recalculated daily from SEC filings and market data. Sign up free for real-time score change alerts.

Share Dilution History

DARE shares outstanding have increased 2.9% from 14.56M (Mar 2026) to 14.98M (May 2026). Each increase represents potential dilution to existing shareholders.

Date Shares Outstanding Public Float Change
May 16, 202614.98M13.70M▲ 2.88%
Apr 03, 202614.56M13.31M▲ 0.18%
Mar 30, 202614.56M13.29M▲ 1.89%

Share counts sourced from verified regulatory filings. Increases indicate dilution events.

Track DARE Dilution Risk in Real-Time
DilutionWatch monitors SEC filings 24/7 and alerts you the moment DARE files a shelf registration, ATM offering, warrant notice, or convertible note. Free tier available — no credit card required.
Start Tracking DARE — Free
Email alert within minutes of any SEC filing Daily DilutionScore™ recalculation Score history & trend tracking Tracks 8,000+ tickers simultaneously

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,490+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for DARE
DARE FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.